Cadre Holdings (CDRE) Q3 2026 Earnings Call Transcript

Cadre Holdings reported Q3 2026 sales of $202.9 million, up 30% year over year, adjusted EBITDA of $41.1 million, up 38%, and net income up 46%; adjusted EBITDA margin expanded 110 basis points to 20.2%. Management raised 2026 revenue guidance to $756 million–$769 million and adjusted EBITDA guidance to $140 million–$144 million for the second consecutive quarter, and authorized a $100 million share repurchase program. Growth included acquisition contributions and 10% organic revenue growth excluding distribution, while management cited lower distribution revenue and unfavorable Alpha-business mix as headwinds; net leverage was 2.2x.

Analysis

The quality of the quarter is better than the headline growth rate, but less broad than it first appears: the EOD outperformance included NGABS work shipped a quarter early, while distribution was soft. That creates a near-term comparison and shipment-timing risk; Q4’s implied revenue and margin profile is below Q3, so the next test is whether armor, duty gear, and nuclear orders refill backlog rather than whether another quarterly beat occurs. The reported 10% organic growth excludes distribution and should not be extrapolated against the full-year 3–4% organic outlook without reconciling definitions.

The more durable upside is operating leverage after integration. Acquired businesses and Alpha mix are currently diluting the margin trajectory; Alien Gear facility consolidation is a roughly 12-month execution project, with full benefits described as more likely in 2028. Precision fabrication adds EOD supply control, but is too small to move consolidated results directly. AI workflow examples are promising, not yet evidence of material savings. Contract awards and IDIQ ceilings also convert to revenue only as funded orders ship.

The buyback is supportive at the margin, but authorization is not a commitment and management says M&A remains the priority. At 2.2x net leverage, larger deals could compete with repurchases and increase integration risk. Near term, strong results may support sentiment; over 1–3 months, watch Q4 conversion and backlog replenishment. Over 6–18 months, margin realization and acquisition execution matter more than geopolitical demand claims. No valuation data are supplied, so the earnings beat alone does not establish attractive entry value.

Key Decisions for Investors

• Treat CDRE as a conditional long, not a chase: consider entry after the initial earnings reaction if the share price stabilizes and subsequent reporting confirms replenishment in armor/duty-gear backlog and delivery against the Q4 outlook. The upside case is sustained organic demand plus acquired-margin improvement; the downside is shipment timing unwinding into weaker sequential results.
• Use the next quarter as the key 1–3 month catalyst check: monitor NGABS timing, distribution, backlog by product area, and adjusted EBITDA margin. If backlog continues to contract beyond the expected shipment effect or guidance is cut, the pull-forward thesis is confirmed and the long case weakens.
• For a 6–18 month thesis, track Alien Gear facility transition, acquired-business margins, and cash conversion before underwriting margin expansion or buyback support. Failure to show improving acquired margins through 2027, or a larger acquisition that raises leverage without clear returns, would falsify the operating-leverage thesis.
• Do not capitalize the full BEMO contract ceiling or RCMP opportunity as secured revenue. Verify funded orders, shipment schedules, and customer concentration; award delays or cancellations are downside catalysts.